Increased riboflavin production by manipulation of inosine 5′-monophosphate dehydrogenase in Ashbya gossypii

Applied Microbiology and Biotechnology

Volumn 99, Issue 22, 2015, Pages 9577-9589

  Buey, Rubén M ^a   Ledesma Amaro, Rodrigo ^c   Balsera, Mónica ^b   de Pereda, José María ^a   Revuelta, José Luis ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b INSTITUTO DE RECURSOS NATURALES Y AGROBIOLOGÍA DE SALAMANCA   (Spain)

^c NONE

Author keywords

Ashbya gossypii; Inosine 5 monophosphate dehydrogenase; Metabolic engineering; Riboflavin

Indexed keywords

ENZYMES; METABOLISM; MOBILE SECURITY; NUCLEIC ACIDS; NUCLEOTIDES; POSITIVE IONS;

ASHBYA GOSSYPII; BIOSYNTHETIC PATHWAY; GUANINE NUCLEOTIDES; METABOLIC ENGINEERING APPROACH; MONOPHOSPHATES; RATE-LIMITING STEPS; RIBOFLAVIN; STRUCTURAL CHARACTERIZATION;

METABOLIC ENGINEERING;

INOSINATE DEHYDROGENASE; RIBOFLAVIN;

AMINO ACID; BIOENGINEERING; CATALYSIS; ENZYME ACTIVITY; EXCRETION; FUNGUS; GENE EXPRESSION; METABOLISM; NUCLEIC ACID; VITAMIN;

ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ANALYSIS; ENZYME STRUCTURE; EREMOTHECIUM GOSSYPII; GENE OVEREXPRESSION; GENETIC MANIPULATION; METABOLIC ENGINEERING; METABOLIC FLUX ANALYSIS; NONHUMAN; PROTEIN FOLDING; WILD TYPE; BIOSYNTHESIS; ENZYMOLOGY; EREMOTHECIUM; GENE EXPRESSION; GENETICS; METABOLISM;

EREMOTHECIUM GOSSYPII; FUNGI;

EREMOTHECIUM; GENE EXPRESSION; IMP DEHYDROGENASE; METABOLIC ENGINEERING; METABOLIC FLUX ANALYSIS; RIBOFLAVIN;

EID: 84946479566     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-015-6710-2     Document Type: Article

References (64)

1. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH (2010) PHENIX: a comprehensive python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66(Pt 2):213–221. doi:10.1107/S0907444909052925
2. Allison AC, Eugui EM (2000) Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47(2–3):85–118
3. Alonso-García N, Inglés-Prieto A, Sonnenberg A, de Pereda JM (2009) Structure of the calx-β domain of the integrin β4 subunit: insights into function and cation-independent stability. Acta Crystallogr D Biol Crystallogr 65(Pt 8):858–871. doi:10.1107/S0907444909018745
4. Bacher A, Eberhardt S, Richter G (1996) Biosynthesis of riboflavin. In: Neidhardt FC, Curtiss III R, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff WS, Riley M, Schaechter M, Umbarger HE (eds) Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington DC, pp. 657–664
5. Bacher A, Eberhardt S, Fischer M, Kis K, Richter G (2000) Biosynthesis of vitamin B2 (riboflavin). Annu Rev Nutr 20:153–167. doi:10.1146/annurev.nutr.20.1.153
6. Bateman A (1997) The structure of a domain common to archaebacteria and the homocystinuria disease protein. Trends Biochem Sci 22(1):12–13
7. Benson DA, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW (2014) GenBank. Nucleic Acids Res 42(Database issue):D32–D37. doi:10.1093/nar/gkt1030
8. Braun-Sand SB, Peetz M (2010) Inosine monophosphate dehydrogenase as a target for antiviral, anticancer, antimicrobial and immunosuppressive therapeutics. Future Med Chem 2(1):81–92. doi:10.4155/fmc.09.147
9. Castresana J (2000) Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis. Mol Biol Evol 17(4):540–552
10. Chong CR, Qian DZ, Pan F, Wei Y, Pili R, Sullivan Jr DJ, Liu JO (2006) Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target. J Med Chem 49(9):2677–2680. doi:10.1021/jm051225t
11. Cossins EA, Chen L (1997) Folates and one-carbon metabolism in plants and fungi. Phytochemistry 45(3):437–452
12. Dietrich FS, Voegeli S, Brachat S, Lerch A, Gates K, Steiner S, Mohr C, Pohlmann R, Luedi P, Choi S, Wing RA, Flavier A, Gaffney TD, Philippsen P (2004) The Ashbya gossypii genome as a tool for mapping the ancient Saccharomyces cerevisiae genome. Science 304(5668):304–307. doi:10.1126/science.1095781
13. Dobie F, Berg A, Boitz J, Jardim A (2007) Kinetic characterization of inosine monophosphate dehydrogenase of Leishmania donovani. Mol Biochem Parasitol 152(1):11–21. doi:10.1016/j.molbiopara.2006.11.007
14. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66(Pt 4):486–501. doi:10.1107/S0907444910007493
15. Forster C, Santos MA, Ruffert S, Kramer R, Revuelta JL (1999) Physiological consequence of disruption of the VMA1 gene in the riboflavin overproducer Ashbya gossypii. J Biol Chem 274(14):9442–9448
16. Gan L, Seyedsayamdost M, Shuto S, Matsuda A, Petsko G, Hedstrom L (2003) The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase. Biochemistry 42(4):857–863. doi:10.1021/bi0271401
17. Gattiker A, Rischatsch R, Demougin P, Voegeli S, Dietrich FS, Philippsen P, Primig M (2007) Ashbya Genome Database 3.0: a cross-species genome and transcriptome browser for yeast biologists. BMC Genomics 8:9. doi:10.1186/1471-2164-8-9
18. Gilbert H, Lowe C, Drabble W (1979) Inosine 5′-monophosphate dehydrogenase of Escherichia coli. Purification by affinity chromatography, subunit structure and inhibition by guanosine 5′-monophosphate. Biochem J 183(3):481–494
19. Gross SS, Levi R (1992) Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267(36):25722–25729
20. Hedstrom L (2009) IMP dehydrogenase: structure, mechanism, and inhibition. Chem Rev 109(7):2903–2928. doi:10.1021/cr900021w
21. Hedstrom L, Liechti G, Goldberg JB, Gollapalli DR (2011) The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors. Curr Med Chem 18(13):1909–1918
22. Hyle J, Shaw R, Reines D (2003) Functional distinctions between IMP dehydrogenase genes in providing mycophenolate resistance and guanine prototrophy to yeast. J Biol Chem 278(31):28470–28478. doi:10.1074/jbc.M303736200
23. Jaroszewski L, Li Z, Cai XH, Weber C, Godzik A (2011) FFAS server: novel features and applications. Nucleic Acids Res 39 (Web Server issue):W38-44 doi:10.1093/nar/gkr441
24. Jenks MH, Reines D (2005) Dissection of the molecular basis of mycophenolate resistance in Saccharomyces cerevisiae. Yeast 22(15):1181–1190. doi:10.1002/yea.1300
25. Jiménez A, Santos MA, Pompejus M, Revuelta JL (2005) Metabolic engineering of the purine pathway for riboflavin production in Ashbya gossypii. Appl Environ Microbiol 71(10):5743–5751. doi:10.1128/AEM.71.10.5743-5751.2005
26. Jiménez A, Santos MA, Revuelta JL (2008) Phosphoribosyl pyrophosphate synthetase activity affects growth and riboflavin production in Ashbya gossypii. BMC Biotechnol 8:67. doi:10.1186/1472-6750-8-67
27. Juanhuix J, Gil-Ortiz F, Cuni G, Colldelram C, Nicolas J, Lidon J, Boter E, Ruget C, Ferrer S, Benach J (2014) Developments in optics and performance at BL13-XALOC, the macromolecular crystallography beamline at the ALBA synchrotron. J Synchrotron Radiat 21(Pt 4):679–689. doi:10.1107/S160057751400825X
28. Kabsch W (2010) Xds. Acta Crystallogr D Biol Crystallogr 66(Pt 2):125–132. doi:10.1107/S0907444909047337
29. Kato T, Park E (2012) Riboflavin production by Ashbya gossypii. Biotechnol Lett 34(4):611–618. doi:10.1007/s10529-011-0833-z
30. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23(21):2947–2948. doi:10.1093/bioinformatics/btm404
31. Ledesma-Amaro R, Jiménez A, Santos MA, Revuelta JL (2013) Biotechnological production of feed nucleotides by microbial strain improvement. Process Biochem 48:7
32. Ledesma-Amaro R, Santos MA, Jiménez A, Revuelta JL (2014a) Strain design of Ashbya gossypii for single-cell oil production. Appl Environ Microbiol 80(4):1237–1244. doi:10.1128/AEM.03560-13
33. Ledesma-Amaro R, Santos MA, Jiménez A, Revuelta JL (2014b) Tuning single-cell oil production in Ashbya gossypii by engineering the elongation and desaturation systems. Biotechnol Bioeng 111(9):1782–1791. doi:10.1002/bit.25245
34. Ledesma-Amaro R, Buey RM, Revuelta JL (2015) Increased production of inosine and guanosine by means of metabolic engineering of the purine pathway in Ashbya gossypii. Microb Cell Fact 14:58. doi:10.1186/s12934-015-0234-4
35. Long H, Cameron S, Yu L, Rao Y (2006) De novo GMP synthesis is required for axon guidance in Drosophila. Genetics 172(3):1633–1642. doi:10.1534/genetics.105.042911
36. Makowska-Grzyska M, Kim Y, Wu R, Wilton R, Gollapalli D, Wang X, Zhang R, Jedrzejczak R, Mack J, Maltseva N, Mulligan R, Binkowski T, Gornicki P, Kuhn M, Anderson W, Hedstrom L, Joachimiak A (2012) Bacillus anthracis inosine 5′-monophosphate dehydrogenase in action: the first bacterial series of structures of phosphate ion-, substrate-, and product-bound complexes. Biochemistry 51(31):6148–6163. doi:10.1021/bi300511w
37. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ (2007) Phaser crystallographic software. J Appl Crystallogr 40(Pt 4):658–674. doi:10.1107/S0021889807021206
38. McPhillips C, Hyle J, Reines D (2004) Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo. Proc Natl Acad Sci U S A 101(33):12171–12176. doi:10.1073/pnas.0403341101
39. Morrow CA, Valkov E, Stamp A, Chow EW, Lee IR, Wronski A, Williams SJ, Hill JM, Djordjevic JT, Kappler U, Kobe B, Fraser JA (2012) De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans. PLoS Pathog 8(10):e1002957 doi:10.1371/journal.ppat.1002957
40. Murray AW (1971) The biological significance of purine salvage. Annu Rev Biochem 40:811–826. doi:10.1146/annurev.bi.40.070171.004115
41. Nagano N, Orengo CA, Thornton JM (2002) One fold with many functions: the evolutionary relationships between TIM barrel families based on their sequences, structures and functions. J Mol Biol 321(5):741–765
42. Nair V, Shu Q (2007) Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery. Antivir Chem Chemother 18(5):245–258
43. Page RD (1996) TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci 12(4):357–358
44. Park EY, Ito Y, Nariyama M, Sugimoto T, Lies D, Kato T (2011) The improvement of riboflavin production in Ashbya gossypii via disparity mutagenesis and DNA microarray analysis. Appl Microbiol Biotechnol 91(5):1315–1326. doi:10.1007/s00253-011-3325-0
45. Pimkin M, Markham G (2008) The CBS subdomain of inosine 5′-monophosphate dehydrogenase regulates purine nucleotide turnover. Mol Microbiol 68(2):342–359. doi:10.1111/j.1365-2958.2008.06153.x
46. Potterton E, Briggs P, Turkenburg M, Dodson E (2003) A graphical user interface to the CCP4 program suite. Acta Crystallogr D Biol Crystallogr 59(Pt 7):1131–1137
47. Prosise GL, Wu JZ, Luecke H (2002) Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site. J Biol Chem 277(52):50654-50659 doi:10.1074/jbc.M208330200
48. Rao V, Shepherd S, Owen R, Hunter W (2013) Structure of Pseudomonas aeruginosa inosine 5′-monophosphate dehydrogenase. Acta Crystallogr Sect F Struct Biol Cryst Commun 69(Pt 3):243–247. doi:10.1107/s1744309113002352
49. Ratcliffe AJ (2006) Inosine 5′-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases. Curr Opin Drug Discov Devel 9(5):595–605
50. Revuelta JL, Buitrago MJ, Santos MA (1998) Riboflavin biosynthesis in fungi. Patent nr WO9526406 In., C12N15/52(edn: BASF AG (DE))
51. Riera TV, Zheng L, Josephine HR, Min D, Yang W, Hedstrom L (2011) Allosteric activation via kinetic control: potassium accelerates a conformational change in IMP dehydrogenase. Biochemistry 50(39):8508–8518. doi:10.1021/bi200785s
52. Stahmann K, Revuelta J, Seulberger H (2000) Three biotechnical processes using Ashbya gossypii, Candida famata, or Bacillus subtilis compete with chemical riboflavin production. Appl Microbiol Biotechnol 53(5):509-516 doi:10.1007/s002530051649
53. Thompson JD, Gibson TJ, Higgins DG (2002) Multiple sequence alignment using ClustalW and ClustalX. Curr Protoc Bioinformatics Chapter 2:Unit 2.3 doi:10.1002/0471250953.bi0203s00
54. Traut TW (1994) Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140(1):1-22
55. Trzhtsinskaya BV, Abramova ND (1991) Imidazole-2-thiones: synthesis, structure and properties. Sulfur Reports 10:389–421
56. Umejiego NN, Gollapalli D, Sharling L, Volftsun A, Lu J, Benjamin NN, Stroupe AH, Riera TV, Striepen B, Hedstrom L (2008) Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis. Chem Biol 15(1):70–77. doi:10.1016/j.chembiol.2007.12.010
57. Vandamme EJ (1992) Production of vitamins, coenzymes and related biochemicals by biotechnological processes. J Chem Technol Biotechnol 53(4):313–327
58. Wasserstrom L, Lengeler KB, Walther A, Wendland J (2013) Molecular determinants of sporulation in Ashbya gossypii. Genetics 195(1):87–99. doi:10.1534/genetics.113.151019
59. Wendland J, Ayad-Durieux Y, Knechtle P, Rebischung C, Philippsen P (2000) PCR-based gene targeting in the filamentous fungus Ashbya gossypii. Gene 242(1–2):381–391
60. Wendland J, Dunkler A, Walther A (2011) Characterization of α-factor pheromone and pheromone receptor genes of Ashbya gossypii. FEMS Yeast Res 11(5):418–429. doi:10.1111/j.1567-1364.2011.00732.x
61. Winn MD, Isupov MN, Murshudov GN (2001) Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr 57(Pt 1):122–133
62. Zalkin H, Dixon JE (1992) De novo purine nucleotide biosynthesis. Prog Nucleic Acid Res Mol Biol 42:259–287
63. Zhang R, Evans G, Rotella F, Westbrook E, Huberman E, Joachimiak A, Collart FR (1999a) Differential signatures of bacterial and mammalian IMP dehydrogenase enzymes. Curr Med Chem 6(7):537–543
64. Zhang R, Evans G, Rotella FJ, Westbrook EM, Beno D, Huberman E, Joachimiak A, Collart FR (1999b) Characteristics and crystal structure of bacterial inosine-5′-monophosphate dehydrogenase. Biochemistry 38(15):4691–4700. doi:10.1021/bi982858v